Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

Gregersen, H; Peceliunas, V; Remes, K; Schjesvold, F; Abildgaard, N; Nahi, H; Andersen, NF; Vangsted, AJ; Klausen, TW; Helleberg, C; Carlson, K; Frolund, UC; Axelsson, P; Stromberg, O; Blimark, CH; Crafoord, J; Tsykunova, G; Eshoj, HR; Waage, A; Hansson, M; Gulbrandsen, N

Gregersen, H (通讯作者),Aalborg Univ Hosp, Dept Haematol, Molleparkvej 4, DK-9000 Aalborg, Denmark.

EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 108 (1): 34

Abstract

Objective We investigated the efficacy and safety of carfilzomib-containing induction before salvage high-dose melphalan with autologous stem-cell tra......

Full Text Link